Literature DB >> 15875761

Surgical therapy options in polycystic liver disease.

Peter Kornprat1, Herwig Cerwenka, Heinz Bacher, Azab El-Shabrawi, Manfred Tillich, Cord Langner, Hans Joerg Mischinger.   

Abstract

INTRODUCTION: Polycystic liver disease (PLD) is a rare affliction frequently observed in association with polycystic kidney disease. Only symptomatic patients require treatment, which can be conservative or surgical, i.e. laparoscopic or conventional. We report the results of our experience in the surgical management of polycystic liver disease.
METHODS: Between 1994 and 2003, 19 patients (16 female, 3 male) were referred to our center for the management of PLD. Their median age was 50 years (range 33-72). All were symptomatic and their cysts had a median diameter of 11 cm (range 5-22).
RESULTS: Laparoscopic management was undertaken in eight patients, with one conversion to open technique because of bleeding from a superficial hepatic vein. An open procedure was performed in 11 patients: one left hemihepatectomy, deroofing in two patients, segment resection 2/3 plus deroofing in six patients, and segment resection 5/6 plus deroofing in two patients. Four patients had complications: one case of biliary leakage was managed conservatively; two patients had pneumothorax caused by the cava catheter inserted for anesthesia, and one patient's abdominal drain tore off and had to be removed by relaparotomy on the fourth postoperative day. Median follow-up of all patients was 49 months (range 7-98). In one patient there was symptomatic recurrence with hepatomegaly and compression of the inferior vena cava 84 months after the first operation.
CONCLUSIONS: Careful selection of patients and meticulous surgical technique are recommended in the management of PLD. The treatment of choice for symptomatic Gigot or Morino type 1 PLD is laparoscopic surgery, and for advanced stage PLD combined hepatic resection and cyst fenestration.

Entities:  

Mesh:

Year:  2005        PMID: 15875761     DOI: 10.1007/s00508-005-0309-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  4 in total

Review 1.  Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.

Authors:  Bassam Abu-Wasel; Caolan Walsh; Valerie Keough; Michele Molinari
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  Laparoscopic fenestration of liver cysts in polycystic liver disease results in a median volume reduction of 12.5%.

Authors:  Loes van Keimpema; Jelle P Ruurda; Miranda F Ernst; Hendrikus J A A van Geffen; Joost P H Drenth
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

3.  Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patients.

Authors:  Josue Barahona-Garrido; Jesus Camacho-Escobedo; Eduardo Cerda-Contreras; Jorge Hernandez-Calleros; Jesus K Yamamoto-Furusho; Aldo Torre; Misael Uribe
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

4.  Laparoscopic surgery and polycystic liver disease: Clinicopathological features and new trends in management.

Authors:  Aleix Martinez-Perez; Antonio Alberola-Soler; Carlos Domingo-Del Pozo; Beatriz Pemartin-Comella; Elias Martinez-Lopez; Antonio Vazquez-Tarragon
Journal:  J Minim Access Surg       Date:  2016 Jul-Sep       Impact factor: 1.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.